Surgical treatment of hormone-producing adrenocortical carcinoma;Kirurgisk behandling av hormonproduserende binyrebarkkarsinom med levermetastaser

Tidsskrift for den Norske Laegeforening

Volumn 124, Issue 23, 2004, Pages 3061-3063

  Nermoen, Ingrid ^a   Foss, Aksel ^a,b   Holte, Harald ^a,b   Mathisen, Øystein ^a   Brekke, Inge B ^a   Line, Pål Dag ^a   Bergan, Anstein ^a  

^a Medisinsk Avdeling   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID HORMONE;

ADRENAL CORTEX CARCINOMA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; PROGNOSIS; TREATMENT OUTCOME; VIRILIZATION; ADJUVANT CHEMOTHERAPY; ADRENAL CORTEX TUMOR; CARCINOMA; LIVER TUMOR; METASTASIS; PALLIATIVE THERAPY; RADIOGRAPHY; SECRETION; TUMOR RECURRENCE;

ADRENAL CORTEX NEOPLASMS; ADULT; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CUSHING SYNDROME; FEMALE; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 14644417137     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wei CY, Chen KK, Chen MT et al. Adrenal cortical carcinoma with tumor thrombus invasion of inferior vena cava. Urology 1995; 45: 1052-4.
2. MacFarlane DA. Cancer of the adrenal cortex: the natural history, prognosis and treatment in a study of fifty-five cases. Ann R Coll Surg Engl 1958; 23: 155-86.
3. Norton JA. Adrenal tumors. I: DeVita VT, Hellman S, Rosenberg SA, red. Cancer: principles and practice of oncology. 5. utg. Philadelphia: Lippincott-Raven 1997, 1659-77.
4. Cohn K, Gottesman L, Brennan M. Adrenocortical carcinoma. Surgery 1986; 6: 1170-7.
5. Schulick RD, Brennan MF. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol 1999; 6: 719-26.
6. Crucitti F, Bellantone R, Ferrante A et al. The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group. Surgery 1996; 119: 161-70.
7. Haak HR, Hermans J, van de Velde CJ et al. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer 1994; 69: 947-51.
8. Andersen A, Warren DJ, Nome O et al. A high-pressure liquid chromatographic method for measuring mitotane [1,1-(o,p′-Dichlorodiphenyl) -2,2-dichloroethane] and its metabolite 1,1-(o,p′-Dichlorodiphenyl)-2,2- dichloroethene in plasma. Ther Drug Monit 1995; 17: 526-31.
9. Plager JE. Carcinoma of the adrenal cortex: clinical description, diagnosis, and treatment. Int Adv Surg Oncol 1984; 7: 329-53.
10. Soreide JA, Brabrand K, Thoresen SO. Adrenal cortical carcinoma in Norway, 1970-1984. World J Surg 1992; 16: 663-7.
11. Icard P, Chapuis Y, Andreassian B et al. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992; 112: 972-9.
12. Zografos GC, Driscoll DL, Karakousis CP et al. Adrenal adenocarcinoma: a review of 53 cases. J Surg Oncol 1994; 55: 160-4.
13. Venkatesh S, Mickey RC, Sellin RV et al. Adrenal cortical carcinoma. Cancer 1989 1; 64: 765-9.
14. Luton JP, Cerdas S, Billaud L et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med 1990; 322: 1195-201.
15. Khorram-Manesh A, Ahlman H, Jansson S et al. Adrenocortical carcinoma: surgery and mitotane for treatment and steroid profiles for follow-up. World J Surg 1998; 22: 605-11.
16. Norsk Neuroendokrin Tumor Gruppe. Neuroendokrine tumorer, en veiledning til diagnostikk og behandling 2003, side 50-52. Kreftforeningen www.kreft.no. (11.3.2002).
17. Bergenstal D, Lipsett M, Moy R et al. Regression of adrenal cancer and suppression of adrenal function in men by o,p′-DDD. Trans Assoc Am Physicians 1959; 72: 341.
18. Khan TS, Imam H, Juhlin C et al. Streptozocin and o,p′-DDD in the treatment of adrenocortical cancer patients: long-term survival in its adjuvant use. Ann Oncol 2000; 11: 1281-7.
19. Allolio B, Hahner S, Weismann D et al. Management of adrenocortical carcinoma. Clin Endocrinol 2004; 60: 273-83.
20. Geelhoed GW, Dunnick NR, Doppman JL. Management of intravenous extensions of endocrine tumors and prognosis after surgical treatment. Am J Surg 1980; 139: 844-8.